Ra Capital Management, L.P. I Teos Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
A detailed history of Ra Capital Management, L.P. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,649,057 shares of ITOS stock, worth $36.7 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
3,649,057
Previous 2,092,259
74.41%
Holding current value
$36.7 Million
Previous $16.1 Million
35.57%
% of portfolio
0.45%
Previous 0.26%
Shares
7 transactions
Others Institutions Holding ITOS
# of Institutions
139Shares Held
36.5MCall Options Held
121KPut Options Held
738K-
Black Rock Inc. New York, NY3.73MShares$37.6 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$31 Million0.81% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$27.6 Million23.54% of portfolio
-
Tang Capital Management LLC San Diego, CA2.69MShares$27.1 Million1.04% of portfolio
-
Jpmorgan Chase & CO New York, NY1.98MShares$20 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $358M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...